ResearchMoz.us include new market research report " Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market 2014-2018: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.
China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.
View Full Report with TOC at: http://www.researchmoz.us/research-report-on-china-porcine-reproductive-and-respiratory-syndrome-prrs-vaccine-industry--2014-2018-report.html
The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.
According to National Compulsory Immunization Plan of Animal Epidemic Diseases in 2014 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly-pathogenic PRRS. The government is responsible for the expenses. Currently highly pathogenic PRRS vaccines are purchased by the government through invitation for bidding in China.
The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high-end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign-funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.
Browse More related reports to Vaccines at: http://www.researchmoz.us/vaccines-market-reports-79.html
Through this report, the readers can acquire the following information:
- Incidence Status of Porcine Reproductive and Respiratory Syndrome
- Status of China Breeding Industry
- Policy Environment and Government Procurement of PRRS Vaccines in China
- Supply and Demand Status of PRRS Vaccines in China
- Major Manufacturers of PRRS Vaccines and the Operation Status in China
- Prospect of China PRRS Vaccine Industry in China
About Us:
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Mrs.Sheela AK
Tel:+1-518-618-1030
Toll Free: 866-997-4948
Email: sales@researchmoz.us
0 comments:
Post a Comment